(E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide

C143H200N26O24S5 — CID 159370637

IUPAC(E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide
SMILESCCCN(CCC)c1ccc(/C(C)=C(\C#N)S(=O)(=O)NCCOC)cc1.CCN(CC)c1ccc(/C(C)=C(\C#N)S(=O)(=O)NCCOC)cc1.COCCNC(=O)/C(C#N)=C(\C)c1ccc(N2CCN(C)CC2)cc1.COCCNC(=O)/C(C#N)=C(\C)c1ccc(N2CCOCC2)cc1.COCCNC(=O)/C(C#N)=C(\C)c1ccc(NCCN2CCOCC2)cc1.COCCNS(=O)(=O)/C(C#N)=C(\C)c1ccc(N(C)C)cc1.COCCNS(=O)(=O)/C(C#N)=C(\C)c1ccc(N2CCCCC2)cc1.COCCNS(=O)(=O)/C(C#N)=C(\C)c1ccc(N2CCOCC2)cc1
InChIInChI=1S/C20H28N4O3.C19H26N4O2.C19H29N3O3S.C18H25N3O3S.C18H23N3O3.C17H23N3O4S.C17H25N3O3S.C15H21N3O3S/c1-16(19(15-21)20(25)23-8-12-26-2)17-3-5-18(6-4-17)22-7-9-24-10-13-27-14-11-24;1-15(18(14-20)19(24)21-8-13-25-3)16-4-6-17(7-5-16)23-11-9-22(2)10-12-23;1-5-12-22(13-6-2)18-9-7-17(8-10-18)16(3)19(15-20)26(23,24)21-11-14-25-4;1-15(18(14-19)25(22,23)20-10-13-24-2)16-6-8-17(9-7-16)21-11-4-3-5-12-21;1-14(17(13-19)18(22)20-7-10-23-2)15-3-5-16(6-4-15)21-8-11-24-12-9-21;1-14(17(13-18)25(21,22)19-7-10-23-2)15-3-5-16(6-4-15)20-8-11-24-12-9-20;1-5-20(6-2)16-9-7-15(8-10-16)14(3)17(13-18)24(21,22)19-11-12-23-4;1-12(13-5-7-14(8-6-13)18(2)3)15(11-16)22(19,20)17-9-10-21-4/h3-6,22H,7-14H2,1-2H3,(H,23,25);4-7H,8-13H2,1-3H3,(H,21,24);7-10,21H,5-6,11-14H2,1-4H3;6-9,20H,3-5,10-13H2,1-2H3;3-6H,7-12H2,1-2H3,(H,20,22);3-6,19H,7-12H2,1-2H3;7-10,19H,5-6,11-12H2,1-4H3;5-8,17H,9-10H2,1-4H3/b19-16+;18-15+;19-16+;18-15+;3*17-14+;15-12+
InChIKeyLJRSEFOCYJASPM-BJBGDZINSA-N
MW2827.67 g/mol
LogP15.47
Rot. Bonds62

About (E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide

(E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide (PubChem CID 159370637) has the molecular formula C143H200N26O24S5 and a molecular weight of 2827.67 g/mol. Its IUPAC name is (E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide.

Molecular Properties

Compound Name(E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide
PubChem CID159370637
Molecular FormulaC143H200N26O24S5
Molecular Weight2827.67 g/mol
Exact Mass2825.38
IUPAC Name(E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide
SMILESCCCN(CCC)c1ccc(/C(C)=C(\C#N)S(=O)(=O)NCCOC)cc1.CCN(CC)c1ccc(/C(C)=C(\C#N)S(=O)(=O)NCCOC)cc1.COCCNC(=O)/C(C#N)=C(\C)c1ccc(N2CCN(C)CC2)cc1.COCCNC(=O)/C(C#N)=C(\C)c1ccc(N2CCOCC2)cc1.COCCNC(=O)/C(C#N)=C(\C)c1ccc(NCCN2CCOCC2)cc1.COCCNS(=O)(=O)/C(C#N)=C(\C)c1ccc(N(C)C)cc1.COCCNS(=O)(=O)/C(C#N)=C(\C)c1ccc(N2CCCCC2)cc1.COCCNS(=O)(=O)/C(C#N)=C(\C)c1ccc(N2CCOCC2)cc1
InChIInChI=1S/C20H28N4O3.C19H26N4O2.C19H29N3O3S.C18H25N3O3S.C18H23N3O3.C17H23N3O4S.C17H25N3O3S.C15H21N3O3S/c1-16(19(15-21)20(25)23-8-12-26-2)17-3-5-18(6-4-17)22-7-9-24-10-13-27-14-11-24;1-15(18(14-20)19(24)21-8-13-25-3)16-4-6-17(7-5-16)23-11-9-22(2)10-12-23;1-5-12-22(13-6-2)18-9-7-17(8-10-18)16(3)19(15-20)26(23,24)21-11-14-25-4;1-15(18(14-19)25(22,23)20-10-13-24-2)16-6-8-17(9-7-16)21-11-4-3-5-12-21;1-14(17(13-19)18(22)20-7-10-23-2)15-3-5-16(6-4-15)21-8-11-24-12-9-21;1-14(17(13-18)25(21,22)19-7-10-23-2)15-3-5-16(6-4-15)20-8-11-24-12-9-20;1-5-20(6-2)16-9-7-15(8-10-16)14(3)17(13-18)24(21,22)19-11-12-23-4;1-12(13-5-7-14(8-6-13)18(2)3)15(11-16)22(19,20)17-9-10-21-4/h3-6,22H,7-14H2,1-2H3,(H,23,25);4-7H,8-13H2,1-3H3,(H,21,24);7-10,21H,5-6,11-14H2,1-4H3;6-9,20H,3-5,10-13H2,1-2H3;3-6H,7-12H2,1-2H3,(H,20,22);3-6,19H,7-12H2,1-2H3;7-10,19H,5-6,11-12H2,1-4H3;5-8,17H,9-10H2,1-4H3/b19-16+;18-15+;19-16+;18-15+;3*17-14+;15-12+
InChIKeyLJRSEFOCYJASPM-BJBGDZINSA-N
XLogP15.47
TPSA651.19 Ų
H-Bond Donors9
H-Bond Acceptors42
Rotatable Bonds62
Heavy Atoms198
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002827.67
LogP ≤ 515.47
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1042

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_B(251)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'conjugated_nitrile_group', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide?
The IUPAC name of (E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide (CID 159370637) is (E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide.
What is the SMILES notation for (E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide?
The canonical SMILES for (E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide is CCCN(CCC)c1ccc(/C(C)=C(\C#N)S(=O)(=O)NCCOC)cc1.CCN(CC)c1ccc(/C(C)=C(\C#N)S(=O)(=O)NCCOC)cc1.COCCNC(=O)/C(C#N)=C(\C)c1ccc(N2CCN(C)CC2)cc1.COCCNC(=O)/C(C#N)=C(\C)c1ccc(N2CCOCC2)cc1.COCCNC(=O)/C(C#N)=C(\C)c1ccc(NCCN2CCOCC2)cc1.COCCNS(=O)(=O)/C(C#N)=C(\C)c1ccc(N(C)C)cc1.COCCNS(=O)(=O)/C(C#N)=C(\C)c1ccc(N2CCCCC2)cc1.COCCNS(=O)(=O)/C(C#N)=C(\C)c1ccc(N2CCOCC2)cc1.
What is the InChIKey of (E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide?
The InChIKey is LJRSEFOCYJASPM-BJBGDZINSA-N. The full InChI is InChI=1S/C20H28N4O3.C19H26N4O2.C19H29N3O3S.C18H25N3O3S.C18H23N3O3.C17H23N3O4S.C17H25N3O3S.C15H21N3O3S/c1-16(19(15-21)20(25)23-8-12-26-2)17-3-5-18(6-4-17)22-7-9-24-10-13-27-14-11-24;1-15(18(14-20)19(24)21-8-13-25-3)16-4-6-17(7-5-16)23-11-9-22(2)10-12-23;1-5-12-22(13-6-2)18-9-7-17(8-10-18)16(3)19(15-20)26(23,24)21-11-14-25-4;1-15(18(14-19)25(22,23)20-10-13-24-2)16-6-8-17(9-7-16)21-11-4-3-5-12-21;1-14(17(13-19)18(22)20-7-10-23-2)15-3-5-16(6-4-15)21-8-11-24-12-9-21;1-14(17(13-18)25(21,22)19-7-10-23-2)15-3-5-16(6-4-15)20-8-11-24-12-9-20;1-5-20(6-2)16-9-7-15(8-10-16)14(3)17(13-18)24(21,22)19-11-12-23-4;1-12(13-5-7-14(8-6-13)18(2)3)15(11-16)22(19,20)17-9-10-21-4/h3-6,22H,7-14H2,1-2H3,(H,23,25);4-7H,8-13H2,1-3H3,(H,21,24);7-10,21H,5-6,11-14H2,1-4H3;6-9,20H,3-5,10-13H2,1-2H3;3-6H,7-12H2,1-2H3,(H,20,22);3-6,19H,7-12H2,1-2H3;7-10,19H,5-6,11-12H2,1-4H3;5-8,17H,9-10H2,1-4H3/b19-16+;18-15+;19-16+;18-15+;3*17-14+;15-12+.
What are the key properties of (E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide?
(E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide has a molecular weight of 2827.67 g/mol, XLogP of 15.47, 62 rotatable bonds, 9 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-1-cyano-2-[4-(diethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dimethylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-2-[4-(dipropylamino)phenyl]-N-(2-methoxyethyl)prop-1-ene-1-sulfonamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(4-methylpiperazin-1-yl)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-[4-(2-morpholin-4-ylethylamino)phenyl]but-2-enamide;(E)-2-cyano-N-(2-methoxyethyl)-3-(4-morpholin-4-ylphenyl)but-2-enamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-morpholin-4-ylphenyl)prop-1-ene-1-sulfonamide;(E)-1-cyano-N-(2-methoxyethyl)-2-(4-piperidin-1-ylphenyl)prop-1-ene-1-sulfonamide is sourced from PubChem (CID 159370637), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).